down arrow

Piramal Pharma

37
Sell
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0DK501011
  • NSEID: PPLPHARMA
  • BSEID: 543635
INR
220.60
12.3 (5.9%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 54.01 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Piramal Pharma Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
Profit Before Tax
119.00
-160.00
441.00
639.00
Adjustment
1,275.00
1,135.00
787.00
721.00
Changes In working Capital
-234.00
-302.00
-292.00
-619.00
Cash Flow after changes in Working Capital
1,161.00
672.00
935.00
742.00
Cash Flow from Operating Activities
1,004.00
483.00
766.00
597.00
Cash Flow from Investing Activities
-416.00
-1,333.00
-1,737.00
-4,464.00
Cash Flow from Financing Activities
-422.00
817.00
794.00
3,976.00
Net Cash Inflow / Outflow
165.00
-31.00
-176.00
110.00
Opening Cash & Cash Equivalents
53.00
85.00
261.00
151.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
219.00
53.00
85.00
261.00
Compare Cash Flow Results of Piramal Pharma
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
119.8
2399.36
-2,280.00
-95.01%
Adjustment
1275.88
212.2
1,063.00
501.26%
Changes In working Capital
-234.3
20.42
-254.00
-1247.40%
Cash Flow after changes in Working Capital
1161.38
2631.98
-1,470.00
-55.87%
Cash Flow from Operating Activities
1004.54
2152.45
-1,148.00
-53.33%
Cash Flow from Investing Activities
-416.22
-2080.52
1,664.00
79.99%
Cash Flow from Financing Activities
-422.36
5.27
-427.00
-8114.42%
Net Cash Inflow / Outflow
165.96
77.19
88.00
115.00%
Opening Cash & Cash Equivalents
53.23
304.82
-251.00
-82.54%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
219.19
382.01
-163.00
-42.62%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is 107.60% vs -36.86% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
1,004.54
483.89
107.60%